ANTHEM SPORTS + ENTERTAINMENT INC.

Profile

Company Names

ANTHEM SPORTS + ENTERTAINMENT INC.

Addresses

181 UNIVERSITY AVENUE, SUITE 1410, TORONTO, A6 M5H 3M7

Phone Numbers

416-917-6002

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$880,800.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-12-31 
$880,800.00 
$880,800.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEONARD 
 
ASPER 
EXECUTIVE OFFICER, DIRECTOR
ANTHONY 
 
BURROUGHS 
EXECUTIVE OFFICER
ANTHONY 
 
CICIONE 
EXECUTIVE OFFICER
SCOTT 
 
D-AMORE 
EXECUTIVE OFFICER
RICK 
 
EHRMAN 
DIRECTOR
BRENDAN 
 
GALLAGHER 
EXECUTIVE OFFICER
NOLAN 
 
GALLAGHER 
EXECUTIVE OFFICER
MICHELLE 
 
HALL 
EXECUTIVE OFFICER
BRIAN 
 
KENYON 
EXECUTIVE OFFICER
SHANNON 
 
KNAPP 
EXECUTIVE OFFICER
CAROL 
 
MCDANIEL 
EXECUTIVE OFFICER
NIRAL 
 
MERCHANT 
EXECUTIVE OFFICER
CHAD 
 
MIDGLEY 
EXECUTIVE OFFICER
MICHAEL 
 
MURPHY 
EXECUTIVE OFFICER
GLEICHEN RESOURCES LTD.   |  NEXUS ENERGYHOMES, INC.   |  TMG ENERGY CORP   |  DIAMOND FOODS INC   |  TOREX GOLD RESOURCES INC.   |  3D VISION SYSTEMS LLC   |  NATIONAL GENERAL HOLDINGS CORP.   |  HOLY MOUNTAIN BREWING CO   |  AMERICAN HOTEL INCOME PROPERTIES REIT INC.   |  STACKIQ, INC.   |  KINEX PHARMACEUTICALS, INC.   |  DISTRIBU.TD, INC.   |  TRANSEASTERN POWER TRUST   |  SUN CLINICAL LABORATORY, LLC - SERIES 4   |  SUN CLINICAL LABORATORY, LLC - SERIES 3   |  SUN CLINICAL LABORATORY, LLC - SERIES 1   |  SUN CLINICAL LABORATORY, LLC - SERIES 7   |  SUN CLINICAL LABORATORY, LLC - SERIES 5   |  SUN CLINICAL LABORATORY, LLC - SERIES 10   |  SUN CLINICAL LABORATORY, LLC - SERIES 8   |  SUN CLINICAL LABORATORY, LLC - SERIES 9   |  SUN CLINICAL LABORATORY, LLC - SERIES 14   |  PROCTORFREE, INC.   |  SUN CLINICAL LABORATORY, LLC - SERIES 15   |  ROSECLIFF VENTURE PARTNERS, LP   |  AHTOVATION, INC.   |  ADVANTAGE ADVISERS XANTHUS FUND, L.L.C.   |  AKONNI BIOSYSTEMS INC   |  SUN CLINICAL LABORATORY, LLC - SERIES 29   |  ALTERNATE HEALTH CORP.   |  ROSECLIFF VENTURE PARTNERS II, LP   |  ASSABET VALLEY BANCORP   |  AMPLE HILLS HOLDINGS, INC.   |  POST.BID.SHIP., INC.   |  PROPHET ADVANTAGE PARTNERS LP   |  ETHOS GOLD CORP.   |  TENEO PARTNERS, LP   |  ROSECLIFF CREDIT OPPORTUNITY FUND I, L.P.   |  TORTOISE, INC.   |  QUISITIVE TECHNOLOGY SOLUTIONS, INC.   |  PROSPECTOR METALS CORP.   |  BATTERY METALS STREAMING CORP.   |  ANTHEM SPORTS + ENTERTAINMENT INC.   |  MICROSHARE, INC.   |  ANOKIWAVE, INC.   |  ROSECLIFF FRONTIER TECHNOLOGIES FUND I, L.P.   |  AQUILA HARTLAND HOLDINGS, LLC   |  BOOSTLY, INC.   |  SOUTH PACIFIC METALS CORP.   |  ARA LABS INC.   |  NEXT GENERATION SPV 1 LLC   |  NEXT GENERATION SPV 2 LLC   |  NEXT GENERATION SPV 3 LLC   |  WPSL PRO, LLC   |  ROSECLIFF NEXT GENERATION LLC - SERIES RSAI ACCESSS-1   |  ROSECLIFF NEXT GENERATION LLC - SERIES P ACCESS   |  ROSECLIFF NEXT GENERATION LLC - SERIES CBIO ACCESS -1   |  ROSECLIFF NEXT GENERATION LLC - SERIES PVTR ACCESS
ED 
 
NORDHOLM 
EXECUTIVE OFFICER, DIRECTOR
JAIME 
 
POLLACK 
EXECUTIVE OFFICER
LARRY 
 
SCHWARTZ 
EXECUTIVE OFFICER
ARIEL 
 
SHNERER 
EXECUTIVE OFFICER
CHRISTEL 
 
SICE 
DIRECTOR
FRANK 
 
TANKI 
EXECUTIVE OFFICER
SARAH 
 
WEIDMAN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#